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TO THE EDITOR
We note the recent article from Park
et al. (2007) reports a dose-dependent
ACTH induction of the immunomo-
dulatory factor IL-18 in HaCaT kerati-
nocytes. Experiments were conducted,
which implicated both melanocortin-1
receptor (MC1R) and melanocortin-2
receptor (MC2R) in this cellular re-
sponse. Although the authors show a
clear abolition of IL-18 production by
pre-treatment with MC2R antibody, no
statistically significant effect was re-
ported for MC1R antibody pre-treat-
ment. The involvement of MC1R in the
mediation of this response was largely
inferred by the apparent detection of
MC1R protein in HaCaT keratinocytes
by Western immunoblotting. There are,
however, considerable technical issues
regarding the use of antibodies against
MC1R, which can unwittingly lead to
the misidentification of MC1R protein
expression. Therefore, despite the ac-
cumulation of numerous reports de-
scribing the presence of MC1R in
various non-melanocytic human skin
cells, methodological concerns ensure
that this topic is still controversial.
In this regard, we reported recently
(Roberts et al., 2006) that we were
unable to detect MC1R in HaCaT
keratinocytes by immunoblotting using
the same antibody as Park et al. in
Figure 5a of their paper. Our experi-
mentation facilitated specific MC1R
detection by use of both negative
(parental HEK) and positive (MC1R-
transfected HEK) control cells for iden-
tification of the correct size band.
Furthermore, we implemented MC1R
peptide blocking to distinguish the
specific signal from the numerous
non-specific bands obtained with this
antibody. Such controls were not evi-
dent in the report by Park et al. More-
over, we revealed that HaCaT
keratinocytes, in contrast to melano-
cytes, were negative for MC1R expres-
sion using both a sensitive radioligand
binding assay, and a functional cAMP
assay (Roberts et al., 2006).
Unambiguous detection of MC1R in
human cell types is technically de-
manding, mainly owing to the extre-
mely low levels at which MC1R mRNA
and protein are expressed. The best
characterized human cell type known
to express MC1R, the melanocyte, does
so at only 700–1000 receptors per cell
(Donatien et al., 1992; Roberts et al.,
2006). This low abundance is readily
apparent when comparison is made
with either tyrosinase, which is present
at the order of 106–107 molecules per
human melanocyte, or with mouse
MC1R at approximately 104 receptors
per cell (Siegrist et al., 1991). Other
non-melanocytic human cells, if ex-
pressing MC1R protein, would be ex-
pected to do so at levels even lower
than that within melanocytes. Indeed,
we have quantitated MC1R mRNA
levels in various cultured human skin
cells and found that mRNA expression
is at least 11-fold lower than that in
melanocytes (Roberts et al., 2006). If
this expression was translated into
functional receptor, then detection of
such a low level of protein would
require methodology that provided en-
ormous sensitivity as well as extensive
controls to ensure specificity. In our
experience, some of the most common
techniques used by authors to report
MC1R expression are simply inade-
quate to detect such low receptor levels
with the requisite specificity.
In carefully controlled experiments,
we found the antibody-based immu-
noblotting and immunofluorescence
procedures were not sensitive enough
to detect an MC1R signal in human
melanocytes (Roberts et al., 2006). Both
techniques, when used with the most
commonly cited commercial MC1R
antibody (N-19; Santa Cruz, Biotech-
nology, Santa Cruz, CA), displayed
non-specific binding that remained
after peptide blocking, highlighting
cross-reactivity issues that are only
unmasked following implementation
of appropriate controls. The previously
reported detection of MC1R in normal
human cells by immunoblotting (Chak-
raborty and Pawelek, 1993; Moustafa
et al., 2002; Salazar-Onfray et al.,
2002; Rouzaud et al., 2006) is further
complicated by heating cell extracts
above 951C, as we (Sturm et al., 2003)
and others (Eberle, 1988; Schioth et al.,
1996) have shown that this leads to
mass aggregation of the MC1R protein
and consequent retarded gel migration.
It is, however, uncertain from their
methodological description whether
Park et al. also boiled their cell extracts.
Immunofluorescence is generally less
sensitive than immunoblotting, as the
cells cannot be concentrated and there
is no size discrimination of the signal.
A sensitive technique that does not
involve antibody detection is radioli-
gand binding. Our laboratory, and
others (Donatien et al., 1992; Suzuki
et al., 1996) have identified previously
MC1R on human melanocytes using
this technique, with the presence of
the receptor evident from high affinity,
saturable binding that can be specifi-
cally competed by unlabeled melano-
cortins. In our studies, parental HEK,
HaCaT and primary keratinocyte, and
fibroblast cells did not display these
characteristics leading to the conclu-
sion that MC1R protein is absent from
the surface of these cells (Roberts et al.,
2006). Another technique which cir-
cumvents the sensitivity and specificity
issues beset by antibody-mediated
detection of MC1R protein is the
analysis of cAMP production follow-
ing activation of MC1R. This functional
assay further indicated that HaCaT cells
did not harbor active MC1R (Roberts
et al., 2006).
Since our recent documentation of
the literature with respect to MC1R
expression in non-melanocytic humanAbbreviations: MC1R, melanocortin-1 receptor; MC2R, melanocortin-2 receptor
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cells (Roberts et al., 2006), more reports
describing such expression have
emerged (Gatti et al., 2006; Manna
et al., 2006; Hoch et al., 2007; Park
et al., 2007), whereas other articles
have concluded that MC1R is limited to
cutaneous melanocytes only (Li et al.,
2006). Owing to this conflict, it is
imperative that future reports be quan-
titative and include appropriate techni-
cal controls that identify the apparent
MC1R signal to be specific, and
where possible compare this signal
relative to known positive and negative
control cell types. Correlation of pro-
tein expression data with functional
responses will further facilitate accu-
rate assessment of the roles that MC1R
may play beyond its involvement in
pigmentation.
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